Vaishali Pharma Limited (VAISHALI) — Capital Reinvestment Ratio
Latest as of September 2025:
0.22x
Vaishali Pharma Limited (VAISHALI) has a Capital Reinvestment Ratio of 0.22x as of September 2025, meaning it reinvests 0% of its operating cash flow (Rs20.46 Million) in capital expenditures (Rs4.60 Million). See VAISHALI cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.22x
Capex / Operating Cash Flow
Operating Cash Flow
Rs20.46 Million
INR
Capital Expenditures
Rs4.60 Million
INR
Data as of
Sep 2025
Most recent filing
Vaishali Pharma Limited Capital Reinvestment Ratio (2013–2024)
This chart tracks Vaishali Pharma Limited's Capital Reinvestment Ratio across 9 annual periods.
Annual Capital Reinvestment Ratio for Vaishali Pharma Limited (2013–2024)
Year-by-year Capital Reinvestment Ratio for Vaishali Pharma Limited from 2013 to 2024. For live market cap and broader valuation context, see VAISHALI market cap.
| Year | Reinvestment Ratio | Operating CF (INR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.14x | Rs8.07 Million | Rs1.11 Million | ▼ -50.0% |
| 2023 | 0.28x | Rs10.80 Million | Rs2.97 Million | ▼ -58.0% |
| 2022 | 0.66x | Rs13.19 Million | Rs8.65 Million | ▲ +946.8% |
| 2021 | 0.06x | Rs20.11 Million | Rs1.26 Million | ▲ +283.4% |
| 2020 | 0.02x | Rs32.19 Million | Rs526.04K | ▼ -84.3% |
| 2019 | 0.10x | Rs28.48 Million | Rs2.96 Million | ▲ +2431.8% |
| 2017 | 0.00x | Rs8.52 Million | Rs35.00K | ▼ -77.7% |
| 2016 | 0.02x | Rs45.88 Million | Rs847.00K | ▲ +469.9% |
| 2013 | 0.00x | Rs37.97 Million | Rs123.00K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow